SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-052752
Filing Date
2019-10-08
Accepted
2019-10-08 16:21:24
Documents
2
Period of Report
2019-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1626
2 POA DOCUMENT poa.txt EX-24.3_875598 4582
  Complete submission text file 0001209191-19-052752.txt   7655
Mailing Address C/O ACCELERON PHARMA INC 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Sherman Matthew L (Reporting) CIK: 0001325710 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38219 | Film No.: 191142885

Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations